Literature DB >> 26376631

The current status of clinics providing private practice cell therapy in Japan.

Misao Fujita1, Taichi Hatta1, Reina Ozeki2, Akira Akabayashi2.   

Abstract

AIM: To clarify the current state of clinics in Japan that offer unproven cell therapies.
METHODS: Google searches were performed to collect and analyze what kind of clinics provide what kind of cell therapies.
RESULTS: A total of 74 clinics and 247 cases of cell therapies were identified. Various cell therapies, including allograft, were provided not only to seriously ill patients but also to patients with other therapeutic options and healthy individuals. DISCUSSION: Although the practices revealed by our study seem to deviate from international standard, some of these can be construed as legal under the Japanese new act established in 2014.
CONCLUSION: Considering many patients travel to foreign countries to seek therapy, more research from non-English-speaking countries is needed.

Entities:  

Keywords:  Japan; cell therapies; medical tourism; regulations; unproven

Mesh:

Year:  2015        PMID: 26376631     DOI: 10.2217/rme.15.64

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  7 in total

Review 1.  Ethical and Regulatory Challenges with Autologous Adult Stem Cells: A Comparative Review of International Regulations.

Authors:  Tamra Lysaght; Ian H Kerridge; Douglas Sipp; Gerard Porter; Benjamin J Capps
Journal:  J Bioeth Inq       Date:  2017-02-28       Impact factor: 1.352

2.  Financial risks posed by unproven cell interventions: Estimation of refunds from medical expense deductions in Japan.

Authors:  Taichi Hatta; Kazuki Ide; Misao Fujita; Tsunakuni Ikka
Journal:  Stem Cell Reports       Date:  2022-04-21       Impact factor: 7.294

3.  Evaluating the Quality of Website Information of Private-Practice Clinics Offering Cell Therapies in Japan.

Authors:  Hidenori Kashihara; Takeo Nakayama; Taichi Hatta; Naomi Takahashi; Misao Fujita
Journal:  Interact J Med Res       Date:  2016-05-24

Review 4.  The malignant niche: safe spaces for toxic stem cell marketing.

Authors:  Douglas Sipp
Journal:  NPJ Regen Med       Date:  2017-12-19

5.  Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites' marketing of stem cell therapies.

Authors:  Blake Murdoch; Amy Zarzeczny; Timothy Caulfield
Journal:  BMJ Open       Date:  2018-02-28       Impact factor: 2.692

Review 6.  Reflection on the enactment and impact of safety laws for regenerative medicine in Japan.

Authors:  Kayo Takashima; Michael Morrison; Jusaku Minari
Journal:  Stem Cell Reports       Date:  2021-05-20       Impact factor: 7.765

7.  Current status of umbilical cord blood storage and provision to private biobanks by institutions handling childbirth in Japan.

Authors:  Maho Murata; Kenichiro Kawabe; Taichi Hatta; Shoichi Maeda; Misao Fujita
Journal:  BMC Med Ethics       Date:  2022-09-12       Impact factor: 2.834

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.